Dr. Falk Pharma GmbH   Report issue

For profit Phase 2 Phase 3 Phase 4
Founded: Freiburg Germany (1947)

Organization Overview

First Clinical Trial
2001
NCT00128739
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

Dr. Falk Pharma GmbH